What is Dr. Zubair Khalid's research focus?

Dr. Zubair Khalid specializes in molecular virology, mRNA vaccine development, and computational biology, with a focus on avian pathogens like IBDV and Avian Reovirus.

Where is Dr. Zubair Khalid currently working?

Dr. Zubair Khalid is a Postdoctoral Research Associate at the University of Maryland (UMD), specifically within the Department of Animal and Avian Sciences.

Frameshift Mutation: Mechanisms, Effects, and Examples

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-08-11

Introduction to Frameshift Mutations

A frameshift mutation is a type of genetic alteration caused by the insertion or deletion of nucleotides within a coding DNA sequence, where the number of nucleotides added or removed is not a multiple of three. Because the genetic code is read in triplet units called codons, any insertion or deletion that shifts the grouping of nucleotides by one or two positions fundamentally changes the reading frame—the sequential partitioning of the mRNA into codons during translation. Once the frame is shifted, every codon downstream of the mutation site is redefined, producing a completely different amino acid sequence from that point onward.

This is distinct from a substitution, where a single nucleotide is swapped for another without altering the reading frame. Frameshift mutations are almost invariably deleterious because they scramble the protein sequence and frequently introduce premature stop codons, leading to truncated, nonfunctional proteins. The severity of a frameshift mutation depends on its location within the gene, the nature of the inserted or deleted sequence, and whether the resulting mRNA transcript is degraded by cellular quality-control mechanisms. Understanding frameshift mutations requires a firm grasp of how the genetic code is organized and how the translational machinery interprets it.

The Genetic Code and Reading Frame

Codons and Amino Acids

The genetic code is degenerate and universal, consisting of 64 possible codons—three-nucleotide sequences of mRNA—that specify 20 standard amino acids and three stop signals. Of these, 61 codons encode amino acids, while UAA, UAG, and UGA serve as termination codons that halt translation. The code is read sequentially from a start codon (AUG, encoding methionine) in a non-overlapping, comma-free manner. This means that once translation begins, the ribosome moves along the mRNA in strict increments of three nucleotides, never skipping or re-reading positions.

The triplet nature of the code is the critical feature that makes frameshift mutations so damaging. If a mutation inserts or deletes one or two nucleotides, the ribosome's three-nucleotide step size no longer aligns with the original codon boundaries. For example, consider the sequence:

5'-AUG GCA UCC UGA-3' This encodes Met-Ala-Ser-Stop.

If a single adenine is inserted after the start codon:

5'-AUG AGC AUC CUG A-3' The new reading frame produces Met-Ser-Ile-Leu, and the original stop codon is lost entirely. Every amino acid after the insertion point is different, and the protein's structure and function are catastrophically altered.

Open Reading Frame (ORF)

An open reading frame is a continuous stretch of codons that begins with a start codon and ends with a stop codon, with no intervening termination signals. In a healthy gene, the ORF defines the complete protein-coding region. Frameshift mutations disrupt the ORF in two possible ways: they may create a premature stop codon within the coding sequence, truncating the protein, or they may eliminate the natural stop codon, causing translation to continue into the 3' untranslated region (UTR) and produce an extended, aberrant polypeptide. Both outcomes destroy the normal protein product. The concept of the ORF is central to predicting the consequences of a frameshift: if the shifted frame contains a stop codon within the first few codons downstream of the mutation, the protein will be severely truncated; if not, a long, misfolded protein may result. For a broader overview of how mutations alter genes, see Genetic Mutation.

Mechanisms of Frameshift Mutations

Insertion and Deletion

The fundamental mechanism of a frameshift mutation is the addition or removal of nucleotides that are not in multiples of three. Insertions can range from a single base pair to large segments of DNA, while deletions can remove one or more bases. The key determinant of a frameshift is the arithmetic: an insertion of 1, 2, 4, or 5 nucleotides shifts the frame; an insertion of 3 or 6 nucleotides adds whole codons and does not shift the frame, though it still alters the protein by adding extra amino acids. The same logic applies to deletions.

Insertions and deletions arise through several distinct molecular pathways, the most common being errors during DNA replication.

Replication Slippage

Replication slippage, also known as polymerase slippage, is the leading cause of small insertions and deletions, particularly in regions of repetitive DNA. During DNA replication, the template and newly synthesized strands can transiently dissociate from the polymerase. When they re-anneal, the repeated sequences can misalign, causing the polymerase to re-read the same template region (producing an insertion) or skip a portion of the template (producing a deletion).

This mechanism is especially prevalent in homopolymer runs (e.g., a string of 8–10 adenines) and short tandem repeats (e.g., (CA)n). For example, in a template with the sequence AAAAAAAA, the newly synthesized strand may slip backward by one base, causing the polymerase to add an extra adenine. The resulting daughter strand has nine adenines instead of eight, creating a frameshift if this sequence lies within a coding region. The frequency of replication slippage is inversely related to the efficiency of the mismatch repair (MMR) system, which normally corrects such errors. Deficiencies in MMR, as seen in certain hereditary colorectal cancers, dramatically elevate the rate of frameshift mutations.

Mutagens and DNA Damage

Chemical mutagens and DNA-damaging agents can also induce frameshift mutations. Intercalating agents, such as ethidium bromide and acridine orange, insert themselves between adjacent base pairs in the DNA double helix. This distorts the helix and causes the replication machinery to either skip a base (deletion) or add an extra base (insertion) at the site of intercalation. Acridine dyes are classic frameshift mutagens used in laboratory studies because they almost exclusively produce frameshift mutations rather than substitutions.

Ionizing radiation and reactive oxygen species can cause DNA strand breaks and base modifications that, when repaired by error-prone pathways such as non-homologous end joining, may result in small deletions or insertions at the repair junction. Additionally, certain chemotherapeutic agents, including cisplatin, form DNA crosslinks that can stall replication forks and lead to slippage-mediated frameshifts.

Types of Frameshift Mutations

Insertion Frameshifts

Insertion frameshifts occur when one or more nucleotides are added to the coding sequence. A single-base insertion is the most common and most damaging form, as it shifts the reading frame by one position immediately. Insertions of two bases shift the frame by two positions, which is equally disruptive. Insertions of four or five bases also cause frameshifts, though the resulting sequence may be longer before a stop codon is encountered.

The source of the inserted nucleotides can be a duplication of an adjacent sequence (as in replication slippage), the insertion of a transposable element, or the erroneous action of a DNA repair enzyme. Large insertions, such as those from transposons, are often hundreds or thousands of base pairs long; if they are not in multiples of three, they will cause a frameshift. However, if a transposon inserts into an intron or a non-coding region, it may have no effect on the protein product.

Deletion Frameshifts

Deletion frameshifts remove one or more nucleotides from the coding sequence. A single-base deletion shifts the frame by one position in the opposite direction from an insertion. Deletions can arise from replication slippage, from the excision of damaged bases followed by imprecise repair, or from unequal crossing over during meiosis. Unequal crossing over occurs when homologous chromosomes misalign during recombination, leading to a deletion on one chromosome and a duplication on the other. If the deletion removes a number of bases not divisible by three, the result is a frameshift.

Deletions that remove large chromosomal segments can delete entire exons or genes; if the deletion removes a whole number of codons (a multiple of three), the reading frame is preserved, but the protein will lack the corresponding amino acids. Such in-frame deletions can still be pathogenic, but they are mechanistically distinct from frameshift mutations.

Indels

The term "indel" is a portmanteau of insertion and deletion, used when the exact mutational event cannot be unambiguously classified as one or the other—for example, when a sequence has changed from ATCG to ATG, it could be a deletion of C or an insertion of G. In the context of frameshift mutations, indels are simply insertions or deletions whose net effect on the reading frame is what matters. A compound indel that inserts two bases and deletes one base has a net change of +1 nucleotide, causing a frameshift. The distinction between insertion and deletion is often less important than the net nucleotide count modulo three.

For a comprehensive comparison of frameshift mutations with other types of genetic changes, see Many Different Types of Mutation in Genes.

Consequences for Protein Synthesis

Premature Stop Codons

The most common consequence of a frameshift mutation is the introduction of a premature termination codon (PTC) downstream of the mutation site. Because the shifted reading frame is essentially random with respect to the original coding sequence, the probability that a stop codon (UAA, UAG, or UGA) appears within the first few codons of the new frame is relatively high. Statistically, one in every ~21 codons in a random sequence is a stop codon, so a frameshift will typically produce a PTC within 5–10 codons of the mutation.

When a PTC is encountered, the ribosome releases the nascent polypeptide, and the incomplete protein is degraded by cellular proteases. The resulting protein fragment is almost always nonfunctional, as it lacks the C-terminal domains required for proper folding, substrate binding, or enzymatic activity. Even if the PTC occurs near the C-terminus of the protein, the loss of even a few amino acids can disrupt critical structural elements.

Nonsense-Mediated Decay

Eukaryotic cells have a quality-control pathway called nonsense-mediated decay (NMD) that detects and degrades mRNAs containing PTCs. NMD is triggered when a ribosome terminates translation at a PTC that is located more than 50–55 nucleotides upstream of the final exon-exon junction. During pre-mRNA splicing, exon-junction complexes (EJCs) are deposited at exon boundaries; these are normally removed by the translating ribosome during the first pass. If a PTC is encountered before the ribosome has removed all downstream EJCs, the EJC remaining on the mRNA recruits the NMD machinery, leading to mRNA degradation.

NMD is an important protective mechanism, as it prevents the translation of truncated proteins that could have dominant-negative effects. However, NMD is not always complete; some PTC-containing mRNAs escape degradation, particularly if the PTC is near the start codon or in the last exon. In these cases, truncated proteins are produced and may cause disease. The efficiency of NMD varies by tissue and by the specific mutation, contributing to phenotypic variability in genetic disorders.

Examples of Frameshift Mutations in Disease

Cystic Fibrosis

Cystic fibrosis (CF) is caused by mutations in the CFTR gene, which encodes the cystic fibrosis transmembrane conductance regulator, a chloride ion channel. The most common CF mutation, ΔF508, is an in-frame deletion of three nucleotides that removes phenylalanine at position 508. This is not a frameshift mutation. However, frameshift mutations in CFTR account for a small percentage of CF cases and are generally associated with severe disease.

For example, the mutation 394delTT is a deletion of two thymine nucleotides in exon 7 of CFTR. This shifts the reading frame and introduces a PTC shortly downstream, resulting in a severely truncated CFTR protein that is completely nonfunctional. Patients with this mutation typically have pancreatic insufficiency and severe pulmonary disease, as no functional chloride channel is produced. The clinical severity of frameshift mutations in CFTR is generally worse than that of missense mutations, because the former abolish protein function entirely.

Tay-Sachs Disease

Tay-Sachs disease is a lysosomal storage disorder caused by mutations in the HEXA gene, which encodes the alpha subunit of beta-hexosaminidase A. This enzyme degrades GM2 gangliosides in neurons; its deficiency leads to progressive neurodegeneration and death in early childhood.

Several frameshift mutations in HEXA have been identified. One well-characterized mutation is a four-base insertion in exon 11 (1278insTATC), which is common in the Ashkenazi Jewish population. This insertion shifts the reading frame and creates a PTC, resulting in a truncated, nonfunctional enzyme. Because beta-hexosaminidase A is a heterodimer, the mutant alpha subunit cannot assemble with the beta subunit, and the enzyme is completely inactive. The accumulation of GM2 gangliosides in neurons causes the characteristic cherry-red spot on the macula and rapid neurological decline.

Cancer-Associated Frameshifts

Frameshift mutations are frequent drivers of cancer, particularly in genes involved in DNA repair and tumor suppression. The TP53 gene, which encodes the p53 tumor suppressor, is mutated in over 50% of human cancers. While most TP53 mutations are missense, frameshift mutations account for approximately 10–15% of cases. These frameshifts typically produce truncated p53 proteins that lack the C-terminal oligomerization domain, rendering them unable to bind DNA or regulate target genes.

In colorectal cancer, frameshift mutations in microsatellite sequences are a hallmark of mismatch repair deficiency. Genes such as TGFBR2 (transforming growth factor beta receptor 2) contain a polyadenine tract (A10) in their coding region. In MMR-deficient tumors, replication slippage at this tract frequently causes a one-base deletion, shifting the reading frame and inactivating the receptor. This allows tumor cells to escape the growth-suppressive effects of TGF-beta. The presence of such frameshift mutations in microsatellites is used diagnostically to identify tumors with microsatellite instability (MSI), which have distinct prognostic and therapeutic implications.

Methods to Detect and Study Frameshift Mutations

Sanger Sequencing

Sanger sequencing, also known as chain-termination sequencing, is the gold standard for detecting known frameshift mutations in a targeted region. The method uses fluorescently labeled dideoxynucleotides that terminate DNA synthesis at each position, generating a ladder of fragments that are separated by capillary electrophoresis. The resulting electropherogram displays the sequence as a series of peaks, one per nucleotide.

A frameshift mutation is detected as a shift in the peak pattern downstream of the mutation site. For example, if a single-base deletion occurs, the peaks after the deletion will be offset by one position relative to the reference sequence, producing a characteristic "frameshift" pattern in the alignment. Sanger sequencing is highly accurate for single-nucleotide resolution but is limited to amplicons of 500–1000 base pairs per reaction. Typical reaction conditions include 25–35 cycles of PCR amplification using a high-fidelity polymerase such as Phusion or Q5, with an annealing temperature determined by the primer melting temperatures (typically 55–65°C).

Next-Generation Sequencing

Next-generation sequencing (NGS) platforms, such as Illumina sequencing, enable the detection of frameshift mutations across entire genomes or exomes. NGS works by sequencing millions of DNA fragments in parallel, then aligning the reads to a reference genome and identifying variants. Frameshift mutations are identified as insertions or deletions (indels) in the aligned reads.

The detection of indels by NGS is computationally challenging because the alignment algorithms must account for gaps. Modern aligners such as BWA-MEM and variant callers such as GATK HaplotypeCaller use local reassembly to accurately identify indels, including those in repetitive regions. The sensitivity of NGS for frameshift detection depends on sequencing depth; a depth of at least 30× is recommended for clinical variant calling, while 100× or higher is needed for detecting low-frequency mosaic mutations.

Bioinformatics Tools

Several computational tools are used to predict the functional impact of frameshift mutations. The most straightforward approach is to translate the mutant DNA sequence in all three reading frames and identify the resulting protein sequence. Tools such as ExPASy Translate and ORFfinder perform this analysis automatically. More sophisticated tools, such as MutationTaster and PROVEAN, incorporate evolutionary conservation, protein domain information, and the likelihood of NMD to predict whether a frameshift mutation is pathogenic.

For frameshift mutations in known disease genes, databases such as ClinVar and the Human Gene Mutation Database (HGMD) provide curated information on pathogenicity. These resources are essential for interpreting novel frameshift variants in clinical genetic testing.

Common Pitfalls and Misconceptions

Frameshift vs. Point Mutation

A common error is using "point mutation" and "frameshift mutation" interchangeably. A point mutation is a change at a single nucleotide position, which can be a substitution, insertion, or deletion. However, in standard usage, "point mutation" most often refers to a substitution—a single base pair change that does not alter the reading frame. Frameshift mutations are always insertions or deletions, and they always alter the reading frame. A single-nucleotide substitution cannot cause a frameshift, because it does not change the number of nucleotides. For a detailed comparison, see Point Mutation Definition and Point Mutation in DNA.

The 3-Nucleotide Rule

Students frequently misunderstand the "multiple of three" rule. The rule states that a frameshift occurs only when the number of inserted or deleted nucleotides is not a multiple of three. An insertion of 3 nucleotides adds one complete codon and does not shift the frame; an insertion of 6 nucleotides adds two codons and also preserves the frame. However, this does not mean such mutations are harmless—they add extra amino acids to the protein, which can disrupt folding and function. The rule applies only to the reading frame, not to the overall impact on protein function.

Another subtlety is that a deletion of 3 nucleotides removes one codon, preserving the frame but deleting an amino acid. This is an in-frame deletion, exemplified by the ΔF508 mutation in CFTR. Students should be able to calculate whether a given indel is in-frame or frameshift by dividing the net nucleotide change by three.

Position Effects

The location of a frameshift mutation within a gene profoundly affects its consequences. A frameshift near the 5' end of the coding sequence (near the start codon) will alter almost the entire protein, likely producing a completely nonfunctional product. A frameshift near the 3' end (near the natural stop codon) may alter only the last few amino acids and could have a milder effect, especially if the C-terminus is not critical for function.

Additionally, the position of the PTC relative to exon-exon junctions determines whether NMD will degrade the mRNA. A PTC in the last exon typically escapes NMD, resulting in a truncated protein that may have dominant-negative activity. Students should consider both the linear position and the splicing context when predicting the severity of a frameshift mutation.

Frequently Asked Questions

What is a frameshift mutation?

A frameshift mutation is an insertion or deletion of nucleotides in a coding DNA sequence where the number of nucleotides added or removed is not a multiple of three. This shifts the reading frame during translation, causing all downstream codons to be read incorrectly and producing a completely different amino acid sequence.

What are the types of frameshift mutations?

Frameshift mutations are classified as insertions (addition of nucleotides) or deletions (removal of nucleotides). When the exact event is ambiguous, they are called indels. The critical factor is the net number of nucleotides changed: if it is not divisible by three, the mutation causes a frameshift.

Can you give an example of a frameshift mutation?

The 394delTT mutation in the CFTR gene, which causes cystic fibrosis, is a deletion of two thymine nucleotides that shifts the reading frame and creates a premature stop codon. Another example is the 1278insTATC mutation in the HEXA gene, which causes Tay-Sachs disease.

How does a frameshift mutation affect protein synthesis?

A frameshift mutation alters the reading frame, so every codon downstream of the mutation is translated incorrectly. This usually produces a premature stop codon, leading to a truncated protein. The mRNA may also be degraded by nonsense-mediated decay, preventing protein synthesis entirely.

What is the difference between a frameshift and a point mutation?

A point mutation is typically a substitution of a single nucleotide, which does not change the reading frame. A frameshift mutation is an insertion or deletion that changes the number of nucleotides and shifts the reading frame. Point mutations alter a single amino acid (or create a stop codon), while frameshift mutations alter the entire downstream protein sequence.

Why do frameshift mutations often cause severe diseases?

Frameshift mutations are severe because they scramble the entire protein sequence downstream of the mutation and usually introduce premature stop codons. The resulting protein is truncated and nonfunctional, and the mRNA may be degraded by NMD. Unlike missense mutations, which affect only one amino acid, frameshift mutations abolish protein function entirely.

How are frameshift mutations detected?

Frameshift mutations are detected by DNA sequencing, either Sanger sequencing for targeted regions or next-generation sequencing for whole genomes or exomes. Bioinformatics tools align the sequencing reads to a reference genome and identify insertions or deletions. The functional impact can be predicted by translating the mutant sequence and assessing the resulting protein.

What is a frameshift mutation diagram?

A frameshift mutation diagram typically shows a normal DNA sequence with codons grouped in triplets, followed by the same sequence with an inserted or deleted nucleotide. The diagram illustrates how the grouping shifts, changing the amino acid sequence from the mutation point onward. Such diagrams are commonly used in textbooks to visualize the concept.

Key Takeaways

A frameshift mutation is an insertion or deletion of nucleotides not in multiples of three, which shifts the reading frame and alters all downstream codons.
The triplet nature of the genetic code is the fundamental basis for why frameshift mutations are so disruptive.
Replication slippage in repetitive sequences is the most common mechanism, but intercalating agents and DNA damage can also cause frameshifts.
Frameshift mutations typically produce premature stop codons, leading to truncated proteins and often triggering nonsense-mediated decay.
Real-world examples include mutations in CFTR (cystic fibrosis), HEXA (Tay-Sachs disease), and TP53 and TGFBR2 (cancer).
Detection relies on Sanger sequencing, next-generation sequencing, and bioinformatics tools that identify indels and predict pathogenicity.
The severity of a frameshift mutation depends on its position in the gene, the net nucleotide change, and whether the mRNA escapes nonsense-mediated decay.